Biosimilars in the EU: Approval Overview and Therapeutic Areas

The Value of Biosimilar Medicines

Key BIOS facts and Figures – 2025

Streamlining Biosimilar Development: Key Aspects

European Critical Medicines Act

Key BIOS facts and Figures – 2024

Infographic – Medicines Shortages: root causes and policies recommendations

It’s time to protect our medicines!

Infographic – Medicines Manufacturing

<strong><a class=”button small empty” href=”https://www.medicinesforeurope.com/wp-content/uploads/2023/05/Man-campaign-2022.png”>Open</a></strong>

One- Pager: New pricing models for generic medicines

How can we ensure a sustainable healthcare system while safeguarding continuous patient access to medicines?

Open